Literature DB >> 20418192

Identification of substance use and dependence among patients with viral hepatitis.

Colin B Jackson1, Jack Varon, Ann Ho, Kristen M Marks, Andrew H Talal, Mary Jeanne Kreek.   

Abstract

BACKGROUND: As drug abuse and addiction have been shown to decrease adherence to treatment of hepatitis C virus (HCV) or HIV, screening for substance use should be standard clinical practice in those undergoing an evaluation for these diseases. AIMS: To assess the effectiveness of the Kreek-McHugh-Schluger-Kellogg (KMSK) scale to quantify substance use and dependence among patients with viral hepatitis.
METHODS: The KMSK scale, a validated instrument that quantifies lifetime use of alcohol, cocaine, heroin, and tobacco, was distributed to 161 consecutive patients referred to a hepatology clinic at an academic, tertiary-care center over a 1-year period.
RESULTS: Of the 159 patients who returned the KMSK scale, 62% reported illicit drug use and 30% met defined criteria for lifetime dependence on cocaine or heroin. We found that 15% of our population at some time had been co-dependent on cocaine and heroin. The KMSK scale identified significantly more cocaine, heroin, and alcohol use than that detected through the medical record (chi(2)=7.61, p<0.01, chi(2)=9.66, p<0.002, respectively). Cocaine dependence was significantly higher among HCV/HIV co-infected than among mono-infected patients (chi(2)=5.46, p<0.02).
CONCLUSIONS: The KMSK scale may be useful to diagnose drug and alcohol use and dependence among patients undergoing evaluation for treatment of viral hepatitis. Copyright (c) 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20418192      PMCID: PMC2910836          DOI: 10.1016/j.dld.2010.03.002

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  33 in total

1.  Screening and counseling for adolescent alcohol use among primary care physicians in the United States.

Authors:  Susan G Millstein; Arik V Marcell
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

2.  Treatment of hepatitis C infection in injection drug users.

Authors:  M Backmund; K Meyer; M Von Zielonka; D Eichenlaub
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

3.  A two-item conjoint screen for alcohol and other drug problems.

Authors:  R L Brown; T Leonard; L A Saunders; O Papasouliotis
Journal:  J Am Board Fam Pract       Date:  2001 Mar-Apr

4.  Smoking cessation guidelines for health professionals: an update. Health Education Authority.

Authors:  R West; A McNeill; M Raw
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

5.  The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications.

Authors:  Scott H Kellogg; Pauline F McHugh; Kathy Bell; James H Schluger; Rosemary P Schluger; K Steven LaForge; Ann Ho; Mary Jeanne Kreek
Journal:  Drug Alcohol Depend       Date:  2003-03-01       Impact factor: 4.492

6.  Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction.

Authors:  J H Schluger; L Borg; A Ho; M J Kreek
Journal:  Neuropsychopharmacology       Date:  2001-05       Impact factor: 7.853

7.  Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

Authors:  John G McHutchison; Michael Manns; Keyur Patel; Thierry Poynard; Karen L Lindsay; Christian Trepo; Jules Dienstag; William M Lee; Carmen Mak; Jean-Jacques Garaud; Janice K Albrecht
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

8.  Treating hepatitis C in methadone maintenance patients: an interim analysis.

Authors:  Diana L Sylvestre
Journal:  Drug Alcohol Depend       Date:  2002-07-01       Impact factor: 4.492

9.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

Review 10.  Occult hepatitis B.

Authors:  Michael Torbenson; David L Thomas
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

View more
  5 in total

1.  Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity?

Authors:  Eduardo Roque Butelman; Silvia Bacciardi; Angelo Giovanni Icro Maremmani; Maya Darst-Campbell; Joel Correa da Rosa; Mary Jeanne Kreek
Journal:  Am J Addict       Date:  2017-06-27

2.  The Utility of Commonly Used Laboratory Tests to Screen for Excessive Alcohol Use in Clinical Practice.

Authors:  Gina Gough; Laura Heathers; Deonna Puckett; Chi Westerhold; Xiaowei Ren; Zhangsheng Yu; David W Crabb; Suthat Liangpunsakul
Journal:  Alcohol Clin Exp Res       Date:  2015-06-25       Impact factor: 3.455

3.  Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users.

Authors:  Vadim Yuferov; Eduardo R Butelman; Matthew Randesi; Wim van den Brink; Peter Blanken; Jan M van Ree; Mary Jeanne Kreek
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-25       Impact factor: 2.570

4.  Gender-specific association of functional prodynorphin 68 bp repeats with cannabis exposure in an African American cohort.

Authors:  Vadim Yuferov; Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-16       Impact factor: 2.570

5.  Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis.

Authors:  Eduardo R Butelman; Angelo G I Maremmani; Silvia Bacciardi; Carina Y Chen; Joel Correa da Rosa; Mary Jeanne Kreek
Journal:  Front Psychiatry       Date:  2018-06-27       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.